EAM
DTIL icon

Empery Asset Management’s Precision BioSciences DTIL Stock Holding History

Empery Asset Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.8M Sell
1,968,879
-225,756
-10% -$1.04M 13.04% 3
2025
Q4 		$9.13M Buy
+2,194,635
New +$12.5M 8.05% 5

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Empery Asset Management's DTIL Position: Q1 2026 in Review

Empery Asset Management reduced its Precision BioSciences (DTIL) stake by 10% in Q1 2026, selling an estimated $1.04M and leaving 1,968,879 shares worth $10.8M. The position accounts for 13.04% of the portfolio, ranked #3.

Empery Asset Management first reported a position in DTIL in Q4 2025 and has held it in 2 quarters since. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Empery Asset Management held 1,968,879 shares of Precision BioSciences worth $10.8M as of Q1 2026.
  • Empery Asset Management sold 225,756 Precision BioSciences shares in Q1 2026, an estimated $1.04M.
  • Precision BioSciences made up 13.04% of Empery Asset Management's portfolio in Q1 2026, its #3 holding.
  • Empery Asset Management first reported a position in Precision BioSciences in Q4 2025 and has held it in 2 quarters since.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Empery Asset Management's 13F filing for Q1 2026, filed 8 May 2026.